Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06457685 · ClinicalTrials.gov registry record · NA
Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial
A NA study of Peripheral Arterial Disease (PAD), sponsored by Amplitude Vascular Systems.
- Active
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 19
- Study locations
NCT06457685 is a NA study of Peripheral Arterial Disease (PAD) that is active but no longer recruiting, run by Amplitude Vascular Systems. The registered enrollment target is 115 participants. The trial reports 19 study locations across 13 states.
The verdict
NCT06457685, a NA study of Peripheral Arterial Disease (PAD), is active but no longer recruiting, sponsored by Amplitude Vascular Systems.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 19
- Study locations
Study Summary
POWER PAD 2 is a prospective, single-arm, multicenter, non-randomized clinical study designed to demonstrate the safety and effectiveness of the Amplitude Vascular Systems (AVS) Pulse Intravascular Lithotripsy™ (Pulse IVL™) System for treatment of calcified (moderate to severe), stenotic, superficial femoral and popliteal arteries in patients with peripheral arterial disease.
Conditions Studied
Interventions
- DEVICE Pulse Intravascular Lithotripsy (Pulse IVL)
Study Locations (19)
New York
- NYU Langone - New York
- Mount Sinai - New York
- Columbia University and New York Presbyterian Hospital (NYPH) - New York
Ohio
- The Christ Hospital - Cincinnati
- University Hospital- Cleveland Medical Center - Cleveland
- OhioHealth Riverside - Columbus
Pennsylvania
- Mainline Health Lankenau - Bryn Mawr
- UPMC Pinnacle - Mechanicsburg
Texas
- Ascension Seton - Austin
- The Heart Hospital Baylor Plano - Plano
Arkansas
- Arkansas Heart Hospital - Little Rock
California
- Vascular and Interventional Specialists of Orange County - Orange
Colorado
- Advanced Heart and Vein Center - Thornton
Georgia
- Piedmont Heart Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06457685
The ClinicalTrials.gov registry entry for NCT06457685 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amplitude Vascular Systems, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Disease (PAD) appearing as the primary indexed condition, and to 1 intervention - of which Pulse Intravascular Lithotripsy (Pulse IVL) is the first listed.
NCT06457685 reports 19 study locations spanning 13 distinct geographic areas - top geographies include New York, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06457685 about?
NCT06457685 is a clinical study titled "Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial". POWER PAD 2 is a prospective, single-arm, multicenter, non-randomized clinical study designed to demonstrate the safety and effectiveness of the Amplitude Vascular Systems (AVS) Pulse Intravascular Lithotripsy™ (Pulse IVL™) System for treatment of calcified (moderate to severe), stenotic, superficia...
What is the current status of trial NCT06457685?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 115 participants. The study started on 2024-09-05. Estimated completion is 2026-08.
What conditions does trial NCT06457685 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease (PAD).
What interventions are being tested in trial NCT06457685?
The interventions under investigation include: Pulse Intravascular Lithotripsy (Pulse IVL) (DEVICE).
Who is sponsoring clinical trial NCT06457685?
This trial is sponsored by Amplitude Vascular Systems, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06457685 being conducted?
This trial has 19 study locations across Arkansas, California, Colorado, Georgia, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease (PAD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.